Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2001
10/25/2001WO2001079198A1 Pyrazoles for inhibiting protein kinase
10/25/2001WO2001079195A2 Pyridine and pyrazine derivatives as thrombin inhibitors
10/25/2001WO2001079180A2 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001WO2001079173A2 Enamine derivatives as cell adhesion molecules
10/25/2001WO2001079164A2 N-substituted dithiocarbamates for the treatment of biological disorders
10/25/2001WO2001078723A1 Compounds and methods
10/25/2001WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001WO2001019798A3 Inhibitors of factor xa
10/25/2001US20010034448 New compounds, their preparation and use
10/25/2001US20010034362 Pyrrolidine derivatives for vision and memory disorders
10/25/2001US20010034348 Nitric oxide synthase inhibitor; nervous system disorders
10/25/2001US20010034343 Crohn's diseas, antiulcer agents, asthma, emesis
10/25/2001DE10019145A1 New phenyl substituted 4-hydroxy-tetrahydropyridone derivatives useful for control of animal pests and as herbicides
10/25/2001CA2405696A1 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001CA2403490A1 N-substituted dithiocarbamates for the treatment of biological disorders
10/25/2001CA2398446A1 Pyrazoles for inhibiting protein kinases
10/24/2001EP1148055A1 C9 taxane derivatives and pharmaceutical compositions containing them
10/24/2001EP1148053A1 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
10/24/2001EP1147778A1 Stable gel formulation for topical treatment of skin conditions
10/24/2001EP1147107A1 Novel angiogenesis inhibitors
10/24/2001EP1147102A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001EP1147095A1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
10/24/2001EP1147094A1 Non-peptide glp-1 agonists
10/24/2001EP1147088A1 6-arylphenanthridines with pde-iv inhibiting activity
10/24/2001EP0869955B1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/24/2001EP0840601B1 Thip for treating sleep disorders
10/24/2001CN1319094A Imidazolyl derivatives
10/24/2001CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/23/2001US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/23/2001US6307060 Antispasmodic agents
10/23/2001US6307056 Inhibit or modulate protein kinases, in particular jnk protein kinases.
10/23/2001US6307047 Prostaglandin endoperoxide H synthase biosynthesis inhibitors
10/23/2001US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001US6306880 Triazole antifungal agent
10/23/2001US6306874 Enzyme inhibitors such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
10/23/2001US6306860 2,5-pyridinedicarboxylic acid derivatives
10/23/2001US6306857 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanones
10/23/2001US6306853 Dicarboxylic ester derivatives of dihydropyridine compounds
10/23/2001US6306852 Indole derivatives useful as endothelin receptor antagonists
10/23/2001CA2107150C Chromenic derivatives having a triene lateral chain, process for the preparation thereof and pharmaceutical compositions containing them
10/18/2001WO2001077134A2 Process for the preparation of 6-o-propargyl erythromycin derivatives
10/18/2001WO2001077101A1 Chemical compounds
10/18/2001WO2001077080A2 Pyrazole compounds having anti proliferative activity
10/18/2001WO2001077079A2 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
10/18/2001WO2001076629A1 Soluble beta amyloid precursor protein secretion promoters
10/18/2001WO2001076604A1 Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
10/18/2001WO2000071518A3 Heterocyclic analgesic compounds and their use
10/18/2001WO2000035903A3 Thiochromanoyl cyclohexenone derivatives
10/18/2001US20010031877 Eprosartan dihydate and a process for its production and formulation
10/18/2001US20010031781 Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors
10/18/2001US20010031778 Triazole antifungal agent
10/18/2001US20010031768 Triazole antifungal agent
10/18/2001EP1144401A3 Thiochromanoyl cyclohexenone derivatives
10/18/2001DE10112005A1 1-Substituierte 2,5-Dithienylpyrrol-Derivate und filmbildende Materialien 1-Substituted 2,5-dithienylpyrrole derivatives and film-forming materials
10/18/2001CA2405306A1 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
10/18/2001CA2405163A1 Soluble beta amyloid precursor protein secretion promoters
10/18/2001CA2404915A1 Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
10/18/2001CA2403012A1 Chemical compounds
10/17/2001EP1146045A1 Piperidine derivatives having effects on serotonin related systems
10/17/2001EP1146043A1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
10/17/2001EP1144406A1 Antifungal azole derivatives having a fluorinated vinyl group and process for preparing same
10/17/2001EP1144405A1 Triazole compounds with dopamine-d3-receptor affinity
10/17/2001EP1144403A1 Substitued pyrazoles as p38 kinase inhibitors
10/17/2001EP1144401A2 Thiochromanoyl cyclohexenone derivatives
10/17/2001EP1144390A2 Kinase inhibitors
10/17/2001EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144381A2 Substituted benzo[de]isoquinoline-1,3-diones
10/17/2001EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001EP1143970A1 Pyridine compounds, use and preparation thereof
10/17/2001EP1143959A2 Antifungal activity of dicationic molecules
10/17/2001EP1143796A1 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
10/17/2001EP0983265A4 Endothelin receptor antagonists
10/17/2001EP0865438B1 Oxymethoxy-3-aryl-pyrone derivatives
10/17/2001EP0709373B1 Pyrrolidine derivative
10/17/2001CN1318058A 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as CRTP inhibitors
10/17/2001CN1318056A Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
10/17/2001CN1318053A Cyclopentanoue dihydropyridine compounds useful as potassium channel openers
10/17/2001CN1317966A Utilization of aryl (or heteroaryl) azolylcarbinol derivatives in prepn. of medicament for treating troubles mediated by excess of substance P
10/17/2001CN1317965A Compounds having IgE affecting properties
10/17/2001CN1317240A Pyrazole-4-quardri heteroaroylation derivative used as herbicide
10/17/2001CN1073107C Process for 2-substituted benzo [b] thiophene compounds and intermediates thereof
10/17/2001CN1073106C Taxoids compound, preparation thereof, and pharmaceutical compsns. contg. same
10/17/2001CN1073098C Benzothiazolone derivatives
10/17/2001CN1073089C Benzodizaepine derivtive, its compsns. and use of preparing medicines
10/16/2001US6303816 N-2-(4-(4-(2-methanesulfonamidoethyl)phenyl)phenyl)-propyl 2-propanesulfonamide or a pharmaceutically acceptable salt thereof.
10/16/2001US6303793 Intermediates for cyclin-dependent kinase inhibitors
10/16/2001US6303639 Propanolamine derivatives substituted by heterocyclic radicals, processes for their preparation, pharmaceuticals comprising these compounds and their use
10/16/2001US6303636 Arylsulfonylamino hydroxamic acid derivatives
10/16/2001US6303633 Heteroaryl amines as novel acetylcholinesterase inhibitors
10/16/2001US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease
10/16/2001US6303600 Substituted azabicyclic compounds
10/16/2001US6303593 For therapy human immunodeficiency virus infection, aquired immunodeficiency syndrome (aids), inflammatory and immunoregulatory disorder or disease, asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis
10/16/2001US6303541 Substituted thienyl(amino)sulphonyl(thio)ureas as herbicides
10/16/2001US6302837 Benzothiophene, benzofuran and indole compounds
10/16/2001CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001WO2001074809A1 Acylthiophene derivatives and use thereof as drugs
10/11/2001WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001WO2001074805A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/11/2001WO2001074804A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain
1 ... 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 ... 523